JPWO2022214678A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022214678A5 JPWO2022214678A5 JP2023554016A JP2023554016A JPWO2022214678A5 JP WO2022214678 A5 JPWO2022214678 A5 JP WO2022214678A5 JP 2023554016 A JP2023554016 A JP 2023554016A JP 2023554016 A JP2023554016 A JP 2023554016A JP WO2022214678 A5 JPWO2022214678 A5 JP WO2022214678A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- positions
- fusion
- immunogenic composition
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims 38
- 239000000203 mixture Substances 0.000 claims 30
- 241000342334 Human metapneumovirus Species 0.000 claims 26
- 230000002163 immunogen Effects 0.000 claims 25
- 230000004927 fusion Effects 0.000 claims 22
- 125000003275 alpha amino acid group Chemical group 0.000 claims 10
- 238000006467 substitution reaction Methods 0.000 claims 9
- 239000002671 adjuvant Substances 0.000 claims 6
- 239000012634 fragment Substances 0.000 claims 6
- 235000001014 amino acid Nutrition 0.000 claims 5
- 102200015465 rs121912304 Human genes 0.000 claims 5
- 102200019524 rs2230199 Human genes 0.000 claims 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 4
- 229940037003 alum Drugs 0.000 claims 4
- 125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 claims 4
- 230000003472 neutralizing effect Effects 0.000 claims 4
- 235000018102 proteins Nutrition 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 102220266229 rs1335299144 Human genes 0.000 claims 4
- 102220468936 Protein unc-13 homolog A_E80N_mutation Human genes 0.000 claims 3
- 125000000539 amino acid group Chemical group 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 239000004471 Glycine Substances 0.000 claims 2
- 108091005804 Peptidases Proteins 0.000 claims 2
- 239000004365 Protease Substances 0.000 claims 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- UPAZUDUZKTYFBG-HNPUZVNISA-N azane [(2S,3R,4R,5S,6R)-2,5-dihydroxy-6-[[(2R,3R,4R,5S,6R)-6-(hydroxymethyl)-5-phosphonooxy-3-[[(3R)-3-tetradecanoyloxytetradecanoyl]amino]-4-[(3R)-3-tetradecanoyloxytetradecanoyl]oxyoxan-2-yl]oxymethyl]-3-[[(3R)-3-hydroxytetradecanoyl]amino]oxan-4-yl] (3R)-3-hydroxytetradecanoate Chemical compound [NH4+].CCCCCCCCCCCCCC(=O)O[C@H](CCCCCCCCCCC)CC(=O)N[C@H]1[C@H](OC[C@H]2O[C@H](O)[C@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H]2O)O[C@H](CO)[C@@H](OP(O)([O-])=O)[C@@H]1OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC UPAZUDUZKTYFBG-HNPUZVNISA-N 0.000 claims 2
- 238000003776 cleavage reaction Methods 0.000 claims 2
- 235000018417 cysteine Nutrition 0.000 claims 2
- 230000037430 deletion Effects 0.000 claims 2
- 238000012217 deletion Methods 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 230000035772 mutation Effects 0.000 claims 2
- 230000007017 scission Effects 0.000 claims 2
- 239000004475 Arginine Substances 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 210000005220 cytoplasmic tail Anatomy 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 230000005847 immunogenicity Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 238000005829 trimerization reaction Methods 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21167609 | 2021-04-09 | ||
| EP21167609.3 | 2021-04-09 | ||
| PCT/EP2022/059492 WO2022214678A2 (en) | 2021-04-09 | 2022-04-08 | Human metapneumo virus vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024522385A JP2024522385A (ja) | 2024-06-19 |
| JP2024522385A5 JP2024522385A5 (https=) | 2025-04-15 |
| JPWO2022214678A5 true JPWO2022214678A5 (https=) | 2025-04-15 |
Family
ID=75441775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023554016A Pending JP2024522385A (ja) | 2021-04-09 | 2022-04-08 | ヒトメタニューモウイルスワクチン |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20240358812A1 (https=) |
| EP (2) | EP4319804A2 (https=) |
| JP (1) | JP2024522385A (https=) |
| KR (1) | KR20230167017A (https=) |
| CN (1) | CN117279659A (https=) |
| AU (1) | AU2022255923A1 (https=) |
| BR (1) | BR112023017274A2 (https=) |
| CA (1) | CA3210412A1 (https=) |
| MX (1) | MX2023010370A (https=) |
| WO (2) | WO2022214678A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12021552736A1 (en) | 2019-05-20 | 2022-07-11 | Valneva Se | A subunit vaccine for treatment or prevention of a respiratory tract infection |
| JP2026504862A (ja) | 2023-01-18 | 2026-02-10 | ファイザー・インク | 呼吸器疾患に対するワクチン |
| WO2025119162A1 (zh) * | 2023-12-04 | 2025-06-12 | 深圳深信生物科技有限公司 | 偏肺病毒(mpv)疫苗 |
| WO2025126071A1 (en) | 2023-12-14 | 2025-06-19 | Pfizer Inc. | Rna molecules |
| WO2026018181A1 (en) | 2024-07-17 | 2026-01-22 | Pfizer Inc. | Immunogenic compositions and uses thereof |
| CN119971017B (zh) * | 2025-04-16 | 2025-08-05 | 北京华诺泰生物医药科技有限公司 | 一种hmpv疫苗组合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5547871A (en) | 1993-01-25 | 1996-08-20 | American Cyanamid Company | Heterologous signal sequences for secretion of insect controlling proteins |
| ATE509102T1 (de) | 1994-07-15 | 2011-05-15 | Univ Iowa Res Found | Immunomodulatorische oligonukleotide |
| AT408721B (de) | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| JP4188092B2 (ja) | 2001-05-21 | 2008-11-26 | インターツェル・アクチェンゲゼルシャフト | 免疫促進性オリゴデオキシ核酸分子 |
| ATE485056T1 (de) | 2003-03-24 | 2010-11-15 | Intercell Ag | Verbesserte impfstoffe |
| ES2647882T3 (es) | 2011-12-06 | 2017-12-27 | Valneva Austria Gmbh | Compuestos de aluminio para su uso en productos terapéuticos y vacunas |
| EP3236998A1 (en) | 2014-12-24 | 2017-11-01 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Recombinant metapneumovirus f proteins and their use |
| WO2019092002A1 (en) * | 2017-11-07 | 2019-05-16 | Valneva Se | Pharmaceutical compositions for treatment or prevention of viral infections |
| PH12021552736A1 (en) * | 2019-05-20 | 2022-07-11 | Valneva Se | A subunit vaccine for treatment or prevention of a respiratory tract infection |
-
2022
- 2022-04-08 JP JP2023554016A patent/JP2024522385A/ja active Pending
- 2022-04-08 US US18/285,417 patent/US20240358812A1/en active Pending
- 2022-04-08 WO PCT/EP2022/059492 patent/WO2022214678A2/en not_active Ceased
- 2022-04-08 BR BR112023017274A patent/BR112023017274A2/pt unknown
- 2022-04-08 MX MX2023010370A patent/MX2023010370A/es unknown
- 2022-04-08 CA CA3210412A patent/CA3210412A1/en active Pending
- 2022-04-08 US US18/285,416 patent/US20240181034A1/en active Pending
- 2022-04-08 CN CN202280015950.4A patent/CN117279659A/zh active Pending
- 2022-04-08 EP EP22719593.0A patent/EP4319804A2/en active Pending
- 2022-04-08 KR KR1020237028871A patent/KR20230167017A/ko active Pending
- 2022-04-08 AU AU2022255923A patent/AU2022255923A1/en not_active Abandoned
- 2022-04-08 EP EP22716270.8A patent/EP4319802A2/en active Pending
- 2022-04-08 WO PCT/EP2022/059502 patent/WO2022214685A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11998597B2 (en) | Vaccine against RSV | |
| US12162909B2 (en) | Subunit vaccine for treatment or prevention of a respiratory tract infection | |
| ES3058501T3 (en) | Rsv f protein mutants | |
| CA2187083C (fr) | Fragment peptidique de la proteine g du virus respiratoire syncytial, agent immunogene, composition pharmaceutique le contenant et procede de preparation | |
| JP7317047B2 (ja) | インフルエンザウイルスワクチン及びその使用 | |
| WO2020099383A1 (en) | Stabilized pre-fusion rsv f proteins | |
| IL200341A (en) | Method for the preparation of immunogenic particles containing influenza a m2e protein fused to hepatitis b virus core protein | |
| JPH11508769A (ja) | C型肝炎に対するワクチン | |
| KR20230167017A (ko) | 인간 메타뉴모 바이러스 백신 | |
| JPWO2022214678A5 (https=) | ||
| JPH07508520A (ja) | 組合せポリペプチド抗原 | |
| CN115916237A (zh) | 抗病毒病原体的疫苗 | |
| JPWO2023096990A5 (https=) | ||
| HK40098178A (zh) | 人偏肺病毒疫苗 | |
| WO2024178371A1 (en) | Multicistronic vaccine and methods for producing and using the same | |
| HK40051815A (en) | Vaccine against rsv comprising modified f polypeptide | |
| RU2023124900A (ru) | Композиции, содержащие адъюванты sbi, и способы их применения | |
| JPWO2023173032A5 (https=) | ||
| HK1250939B (en) | Vaccine against rsv |